Penn Medicine Provider
Pulmonary Medicine
Jasleen Minhas, MD, MBBS
Accepting new patients
Harron Lung Center Perelman
Make an appointmentCall 215-615-5864

About me

  • Assistant Professor of Medicine (Pulmonary, Allergy and Critical Care) at the Hospital of the University of Pennsylvania
  • Instructor A of Medicine
  • Instructor A of Medicine (Pulmonary, Allergy and Critical Care)

Education and training

  • null
  • null
  • Fellowship: Hospital of the University of Pennsylvania

Insurance accepted

My Locations

Learn about location

Penn Medicine hospital privileges

  • Hospital of the University of Pennsylvania: Has privileges to treat patients in the hospital.
  • Pennsylvania Hospital: Has privileges to treat patients in the hospital.
  • Penn Presbyterian Medical Center: Has privileges to treat patients in the hospital.
  • Penn Medicine Rittenhouse Long-Term Acute Care Hospital
Dr. Minhas is a Penn Medicine physician.

Qualifications and experience

Treatments and Conditions

My research

Scott JV, Moutchia J, McClelland RL, Al-Naamani N, Weinberg E, Palevsky HI, Minhas J, Appleby DK, Smith A, Pugliese SC, Ventetuolo CE, Kawut SM. Novel Liver Injury Phenotypes and Outcomes in Clinical Trial Participants with Pulmonary Hypertension. , Am J Respir Crit Care Med. , 210(8): 2024,1045-1056

Moutchia J, McClelland RL, Al-Naamani N, Appleby DH, Holmes JH, Minhas J, Mazurek JA, Palevsky HI, Ventetuolo CE, Kawut SM. Pulmonary arterial hypertension treatment: an individual participant data network meta-analysis. , Eur Heart J. , 45(21): 2024,1937-1952

Minhas J, Moutchia J, Al-Naamani N, Mazurek JA, Holmes JH, Appleby D, Smith KA, Fritz JS, Pugliese SC, Palevsky HI, Kawut SM. Electrocardiographic Abnormalities and Their Association with Outcomes in Randomized Clinical Trials of Pulmonary Arterial Hypertension. , Journal of the American Thoracic Society, 21(6): 2024,858-865

M. Batson, D. B. Badesch, C. E. Ventetuolo, D. J. Lachant, B. P. Deboisblanc, M. R. Lammi, O. A. Shlobin, S. C. Mathai, R. T. Zamanian, R. Bernardo, D. Grinnan, T. L. Williamson, S. Bartolome, M. Eggert, S. M. Kawut, J. Minhas. Differences in Patient Characteristics and Clinical Outcomes at the Extremes of Physical Activity in Pulmonary Arterial Hypertension (PAH): A Pulmonary Hypertension Association Registry (PHAR) Study. , American Thoracic Society International Conference, San Diego, CA: 2024

Kawut SM, Feng R, Ellenberg SS, Zamanian R, Bull T, Chakinala M, Mathai SC, Hemnes A, Lin G, Doyle M, Andrew R, MacLean M, Stasinopoulos I, Austin E, DeMichele A, Shou H, Minhas J, Song N, Moutchia J, Ventetuolo CE. Pulmonary Hypertension and Anastrozole (PHANTOM): A Randomized, Double-Blind, Placebo-Controlled Trial. , Am J Respir Crit Care Med. : 2024,Epub ahead of print

Pan HM, McClelland RL, Moutchia J, Appleby DH, Fritz JS, Holmes JH, Minhas J, Palevsky HI, Urbanowicz RJ, Kawut SM, Al-Naamani N. Heterogeneity of treatment effects by risk in pulmonary arterial hypertension. , Eur Respir J. , 62(1): 2023,2300190

Hassan SM, Nardelli P, Minhas J, Ash SY, Estépar RSJ, Antkowiak MC, Badlam JB, Piazza G, Estépar RSJ, Washko GR, Rahaghi FN. CT imaging determinants of persistent hypoxemia in acute intermediate-risk pulmonary embolism. , J Thrombolysis. , 56(1): 2023,196-201

M. Batson, J. Minhas, O. A. Shlobin, C. E. Ventetuolo, D. B. Badesch, M. R. Lammi, R. T. Zamanian, N. Al-Naamani, S. M. Kawut. Physical Activity Characteristics in Pulmonary Arterial Hypertension (PAH): The Pulmonary Hypertension Association Registry (PHAR). , American Thoracic Society International Conference, Washington, DC: 2023

Minhas J, Baird G, Appleby D, McClelland R, Min J, Mazurek J, Ventetuolo CE, Al-Naamani N, Kawut SM. Terminal Digit Preference in Endpoints of Pulmonary Arterial Hypertension (PAH) and Chronic Thromboembolic Pulmonary Hypertension (CTEPH). , American Thoracic Society International Conference, Washington, DC. : 2023

Auriemma CL, Minhas J, Blue R, Lapatra T, Kawut SM, Courtright KR. "It's that invisible illness": Patient and clinician perspectives on outcomes in pulmonary arterial hypertension treatment. , Pulm Circ, 13(2): 2023,e12236